Loading…

Browse All Grants

99,167 grants found

Filters
Reset

Showing 241260 of 99,167 grants

Active NON-SBIR/STTR RPGS
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Wistar Institute United States 2021 – 2026

Summary Current HIV curative strategies have proven insufficient to eradicate viral reservoirs or prevent viral rebound after antiretroviral therapy (ART) cessation. The unifying...

$58.4M
USD
Active NON-SBIR/STTR RPGS
Wisconsin Registry for Alzheimer's Prevention
NATIONAL INSTITUTE ON AGING University of Wisconsin-Madison United States 2023 – 2028

PROJECT SUMMARY The Wisconsin Registry for Alzheimer’s Prevention (WRAP) is a longitudinal study that follows a risk-enriched cohort from late-midlife into old age and focuses on...

$58.32M
USD
Active NON-SBIR/STTR RPGS
B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Emory University United States 2022 – 2027

ABSTRACT The Emory Consortium for Innovative HIV/AIDS Vaccine and Cure Research in Nonhuman Primates aims to define the mechanisms of the B and T Cell Biology of Protection from...

$58.14M
USD
Completed NON-SBIR/STTR RPGS
New Horizons in the Prevention and Treatment of Food Allergy
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Johns Hopkins University United States 2024 – 2025

Project Summary: Food allergy affects approximately 5-10% of young children, with highest incidence in the first year of life. Food allergy accounts for almost $25 billion per ye...

$58M
USD
Active NON-SBIR/STTR RPGS
Plasma brain-derived tau: a novel Alzheimer’s disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in blood
NATIONAL INSTITUTE ON AGING University of Pittsburgh At Pittsburgh United States 2023 – 2028

While the Amyloid(A)/Tau(T)/Neurodegeneration(N) framework has been validated against neuropathology, cerebrospinal fluid (CSF) and neuroimaging biomarkers, its implementation in...

$57.94M
USD
Active NON-SBIR/STTR RPGS
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Wistar Institute United States 2021 – 2026

Summary Current HIV curative strategies have proven insufficient to eradicate viral reservoirs or prevent viral rebound after antiretroviral therapy (ART) cessation. The unifying...

$57.81M
USD
Active NON-SBIR/STTR RPGS
Study of Latinos-Investigation of Neurocognitive Aging-Alzheimer's disease
NATIONAL INSTITUTE ON AGING University of California, San Diego United States 2022 – 2028

Abstract By 2060, the CDC projects that the Latino population will experience the largest increase in Alzheimer’s disease and related dementia (ADRD) cases of all US ethnic/racia...

$57.64M
USD
Completed NON-SBIR/STTR RPGS
National Longitudinal Study of Adolescent to Adult Health (Add Health): Wave VI Core Project
NATIONAL INSTITUTE ON AGING University of North Carolina Chapel Hill United States 2021 – 2025

Project Summary This project, developed in response to RFA-AG-21-008, describes core plans for data collection and dissemination of the sixth wave (Wave VI) of the National Longi...

$57.6M
USD
Active NON-SBIR/STTR RPGS
IP24-045, PREVENT: Preparedness through Respiratory Virus Epidemiology and Community Engagement
NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY D... University of California, San Diego United States 2024 – 2029

SUMMARY Monitoring of the incidence, morbidity, and mortality of respiratory infections has largely been performed by collecting and analyzing data from hospitals and clinical la...

$57.53M
USD
Completed NON-SBIR/STTR RPGS
National Longitudinal Study of Adolescent to Adult Health (Add Health): Wave VI Cognition and Early Risk Factors for Dementia Project
NATIONAL INSTITUTE ON AGING University of North Carolina Chapel Hill United States 2021 – 2025

Project Summary Alzheimer's Disease and Related Dementias (ADRD) are projected to affect 14 million Americans by 2050. To date, though, research on the signs and symptoms of ADRD...

$57.37M
USD
Active NON-SBIR/STTR RPGS
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Wistar Institute United States 2021 – 2026

Summary Current HIV curative strategies have proven insufficient to eradicate viral reservoirs or prevent viral rebound after antiretroviral therapy (ART) cessation. The unifying...

$57.37M
USD
Completed NON-SBIR/STTR RPGS
Neural Architecture of the Murine and Human Temporomandibular Joint
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETA... Duke University United States 2022 – 2025

ABSTRACT: Temporomandibular disorders (TMDs) are the most common form of chronic orofacial pain, affecting 5% of U.S. adults. Despite substantial clinical and research interest i...

$57.35M
USD
Active NON-SBIR/STTR RPGS
SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Duke University United States 2022 – 2027

ABSTRACT The ultimate goal of the proposed studies is to contribute to ending the HIV/AIDS epidemic. It has been four decades since the start of the HIV/AIDS epidemic and a prot...

$57.34M
USD
Active NON-SBIR/STTR RPGS
Pediatric Adolescent Virus Elimination (PAVE) Martin Delaney Collaboratory
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Johns Hopkins University United States 2021 – 2026

ABSTRACT The immediate establishment of the latent HIV-1 reservoir in resting memory CD4+ T cells precludes HIV-1 cure, compelling ART for a lifetime in children. The mission of th...

$57.31M
USD
Active NON-SBIR/STTR RPGS
SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Duke University United States 2022 – 2027

ABSTRACT The ultimate goal of the proposed studies is to contribute to ending the HIV/AIDS epidemic. It has been four decades since the start of the HIV/AIDS epidemic and a prot...

$57.2M
USD
Active NON-SBIR/STTR RPGS
Consortium for Translational and Precision Health
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENC... Baylor College of Medicine United States 2024 – 2031

The Consortium for Translational and Precision Health (CTPH) will serve as a unique bi-institutional hub for infrastructure, services, community engagement, and workforce developm...

$57.11M
USD
Active NON-SBIR/STTR RPGS
Center for Clinical and Translational Sciences
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENC... University of Texas Hlth Sci Ctr Houston United States 2024 – 2031

PROJECT SUMMARY/ ABSTRACT Since its inception in 2006, our CCTS has assembled a well-integrated, and high-impact network in Texas including 6 academic institutions: The Universit...

$57.08M
USD
Active NON-SBIR/STTR RPGS
NJ ACTS: A Platform for Translational Science in New Jersey
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENC... Rutgers Biomedical and Health Sciences United States 2024 – 2031

Abstract: After 4 years, the New Jersey Alliance for Clinical and Translational Science (NJ ACTS), a partnership among four institutions, Rutgers, Princeton Universities, the New...

$57.04M
USD
Active NON-SBIR/STTR RPGS
Plasma brain-derived tau: a novel Alzheimer’s disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in blood
NATIONAL INSTITUTE ON AGING University of Pittsburgh At Pittsburgh United States 2023 – 2028

While the Amyloid(A)/Tau(T)/Neurodegeneration(N) framework has been validated against neuropathology, cerebrospinal fluid (CSF) and neuroimaging biomarkers, its implementation in...

$56.94M
USD
Active NON-SBIR/STTR RPGS
REACH: Research Enterprise to Advance a Cure for HIV
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Weill Medical Coll of Cornell Univ United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Despite the success of standard antiretroviral therapy (ART), the need for an HIV cure remains compelling, both to improve the lives of PWH and to bring ab...

$56.84M
USD